Biosenta Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

CNSX:ZRO Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
10 Oct 24	BuyCA$1,200	Amarvir Gill	Individual	20,000	CA$0.06
02 Oct 24	BuyCA$3,696	Amarvir Gill	Individual	44,000	CA$0.084
02 Apr 24	BuyCA$137,552	William Connor	Individual	286,568	CA$0.48
26 Mar 24	BuyCA$42,686	William Connor	Individual	106,716	CA$0.40
21 Feb 24	BuyCA$500,000	Amarvir Gill	Individual	1,250,000	CA$0.40
21 Feb 24	BuyCA$72,506	Dk Financial Canada Inc., Asset Management Arm	Company	181,265	CA$0.40
21 Feb 24	BuyCA$107,182	1698791 Ontario Ltd	Company	267,955	CA$0.40
15 Feb 24	BuyCA$150	Amarvir Gill	Individual	500	CA$0.30

Insider Trading Volume

Insider Buying: ZRO insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ZRO?
Owner Type	Number of Shares	Ownership Percentage
Institutions	2,187,425	6.83%
Private Companies	6,264,685	19.6%
Individual Insiders	9,536,725	29.8%
General Public	14,025,053	43.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.2%.

Top Shareholders

Top 8 shareholders own 56.19% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.6%	1698791 Ontario Ltd	6,264,685	CA$1.7m	0%	no data
14.1%	Amarvir Gill	4,521,237	CA$1.2m	1.44%	no data
13.4%	William Connor	4,298,225	CA$1.2m	0%	no data
6.83%	Dk Financial Canada Inc., Asset Management Arm	2,187,425	CA$601.5k	0%	no data
1.21%	Dene Rogers	388,287	CA$106.8k	0%	no data
0.46%	Edwin Korhonen	147,005	CA$40.4k	0%	no data
0.44%	David Butler	140,905	CA$38.7k	0%	no data
0.13%	Paul Kalata	41,066	CA$11.3k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 12:33
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biosenta Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution